**Core Concept:** Paraneoplastic syndromes are a group of clinical conditions that occur due to the presence of cancer or its treatment. They are caused by various mechanisms such as ectopic hormone production, immune system dysfunction, or direct tumor effects. In the context of this question, hypercalcemia is a paraneoplastic syndrome.

**Why the Correct Answer is Right:** The correct answer is due to ectopic production of the hormone Parathyroid Hormone-Related Peptide (PTHrP). PTHrP is a peptide hormone that regulates calcium and phosphorus homeostasis in the body. In the presence of lymphoma, the tumor cells can produce excessive levels of PTHrP, leading to hypercalcemia. This is different from primary hyperparathyroidism, where the disorder originates from parathyroid gland dysfunction.

**Why Each Wrong Option is Incorrect:**

A. Parathyroid Hormone (PTH): This is the hormone produced by the parathyroid glands responsible for regulating calcium and phosphorus levels in the body. In contrast to PTHrP, the production of PTH is not expected in a lymphoma-related paraneoplastic syndrome.

B. Calcitonin: Calcitonin is produced by the parafollicular cells of the thyroid gland and plays a role in regulating calcium levels. Unlike PTHrP, calcitonin does not contribute to paraneoplastic hypercalcemia in lymphoma.

C. Thyroid-stimulating hormone (TSH): TSH is produced by the pituitary gland and stimulates thyroid gland function. Unlike PTHrP, TSH does not cause paraneoplastic hypercalcemia in lymphoma.

D. Ectopic production of PTHrP: This is the correct answer, as mentioned above.

**Clinical Pearl:** Paraneoplastic syndromes often serve as a warning sign for underlying malignancy and should prompt further evaluation for cancer. In the case of lymphoma-induced hypercalcemia, a thorough clinical examination and investigations may uncover the primary tumor site.

**Correct Answer:** D. Ectopic production of PTHrP.

**Explanation:** Paraneoplastic hypercalcemia in lymphoma is due to the production of PTHrP by the tumor cells. This leads to increased calcium levels in the blood, which can cause symptoms such as polyuria, polydipsia, bone pain, fatigue, and cognitive dysfunction. Early recognition and treatment of this paraneoplastic syndrome can help manage the underlying lymphoma and improve patient outcomes.